Cargando…
Apatinib in refractory radiation-induced brain edema: A case report
RATIONALE: Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has observed to be effective and safe in refractory radiation-induced brain edema, like Avastin did. Till now, there is no case report after apatinib came in the market. PATIENT CO...
Autores principales: | Hu, Wei Guo, Weng, Yi Ming, Dong, Yi, Li, Xiang Pan, Song, Qi-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704783/ https://www.ncbi.nlm.nih.gov/pubmed/29145238 http://dx.doi.org/10.1097/MD.0000000000007358 |
Ejemplares similares
-
Factors predicting a home death among home palliative care recipients
por: Ko, Ming-Chung, et al.
Publicado: (2017) -
Foreign body removal using flexible bronchoscopy in terminal cancer: A case report
por: Jeon, So-Yeon, et al.
Publicado: (2021) -
Truth Telling and Treatment Strategies in End-of-Life Care in Physician-Led Accountable Care Organizations: Discrepancies Between Patients’ Preferences and Physicians’ Perceptions
por: Huang, Hsien-Liang, et al.
Publicado: (2015) -
Impact of Palliative Care Consultation Service on Terminally Ill Cancer Patients: A 9-Year Observational Cohort Study in Taiwan
por: Lu, Ching-Yi, et al.
Publicado: (2016) -
Medical care utilization and costs on end-of-life cancer patients: The role of hospice care
por: Chang, Hsiao-Ting, et al.
Publicado: (2016)